Advanced Solid Tumors
Showing NaN - NaN of 58
Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)
Not yet recruiting
- Advanced Solid Tumors
- LCB84
- Anti-PD-1 monoclonal antibody
-
Los Angeles, California
- +6 more
Jul 4, 2023
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- +3 more
- CCS1477
- +5 more
-
Boston, Massachusetts
- +21 more
Jan 10, 2023
NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
- GDC-6036
- +6 more
-
Duarte, California
- +68 more
Jan 10, 2023
Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- Elimusertib (BAY1895344)
- Pembrolizumab
-
Palo Alto, California
- +15 more
Jan 6, 2023
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +3 more
-
Boston, Massachusetts
- +9 more
Dec 22, 2022
Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,
Recruiting
- Advanced Solid Tumors
- +11 more
-
Boston, Massachusetts
- +4 more
Dec 12, 2022
Advanced Solid Tumors Trial in Worldwide (ALKS 4230, ALKS 4230 + pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- ALKS 4230
- ALKS 4230 + pembrolizumab
-
Denver, Colorado
- +30 more
Nov 23, 2022
Advanced Solid Tumors, HER2-positive Breast Cancer Trial in United States (ZN-A-1041 50mg BID, ZN-A-1041 100mg BID, ZN-A-1041
Recruiting
- Advanced Solid Tumors
- HER2-positive Breast Cancer
- ZN-A-1041 50mg BID
- +12 more
-
Tucson, Arizona
- +6 more
Nov 16, 2022
Advanced Solid Tumors Trial in Worldwide (INCB081776, INCMGA00012)
Recruiting
- Advanced Solid Tumors
-
New Haven, Connecticut
- +19 more
Nov 10, 2022
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)
Completed
- Advanced Malignancy
- +5 more
- AMG 337
-
Los Angeles, California
- +7 more
Nov 3, 2022
Advanced Solid Tumors Trial in United States (FF-10850 Topotecan Liposome Injection)
Recruiting
- Advanced Solid Tumors
- FF-10850 Topotecan Liposome Injection
-
Scottsdale, Arizona
- +5 more
Oct 19, 2022
Advanced Solid Tumors Trial in Japan, United States (DS-8201a (DP1), DS-8201a (DP2), DS-8201a (DP))
Active, not recruiting
- Advanced Solid Tumors
- DS-8201a (DP1)
- +2 more
-
San Diego, California
- +13 more
Oct 4, 2022
Advanced Solid Tumors Trial in United States (mRNA-4359, Pembrolizumab)
Recruiting
- Advanced Solid Tumors
- mRNA-4359
- Pembrolizumab
-
San Francisco, California
- +9 more
Sep 7, 2022
Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)
Terminated
- Advanced Solid Tumors
-
Los Angeles, California
- +29 more
May 21, 2022
Advanced Solid Tumors Trial in United States (KSQ-4279, KSQ-4279 will be combined in separate cohorts, including combination
Recruiting
- Advanced Solid Tumors
- KSQ-4279
- KSQ-4279 will be combined in separate cohorts, including combination with an oral PARPi (poly adenosine diphosphate-ribose polymerase inhibitor)
-
Boston, Massachusetts
- +4 more
Apr 5, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Advanced Solid Tumors Trial in Worldwide (Intervention)
Completed
- Advanced Solid Tumors
- Intervention
-
Birmingham, Alabama
- +48 more
Jan 18, 2022
Advanced Solid Tumors Trial in Boston (sapacitabine and seliciclib)
Completed
- Advanced Solid Tumors
- sapacitabine and seliciclib
-
Boston, Massachusetts
- +1 more
Dec 7, 2021